CClinicalTrials.gg
CompletedNCT04999748Updated Nov 14, 2023

Consumer Knowledge, Attitude, and Behavior Towards Aging Skin

An observational study in Dermatology, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-14.

Sponsored by Northwestern University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1,434
Ages
18 Years and older
Sex
All
01

Study summary

We will conduct a cross-sectional survey from adults 18 years of age and older to examine consumer knowledge, attitudes and behavior towards aging skin.

Read the detailed description

We will perform a cross-sectional survey study to understand the significance of age-related skin changes to consumers. We will recruit participants through ResearchMatch (a national free and secure online tool) and collect the following data:

Demographic information, including age, gender, race/ethnicity, geographic location, and yearly household income

  • How do participants feel towards their own skin and age-related skin changes?
  • Which aging-related skin changes are the most significant?
  • What factors affect how participants feel towards their skin?
  • What role do age-related skin changes play in other aspects of the participants' lives, such as their social and work life?
  • What treatments are participants currently seeking, and what are their goals for these treatments?
  • How much do they prioritize these treatments?
  • What else are they hoping to do?

Using the demographic information, we will also analyze whether there are differences with:

  • Age
  • Gender identity
  • Racial/ethnic identity
  • Marital status
  • Geographic location
  • Yearly household income
02

Conditions studied

  • Dermatology

Keywords

  • Skin care, Anti-aging
03

In context

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Open to male and female English-speaking adults(18 years or older)

Inclusion criteria

  • The study will include English-speaking adults (18 years or older) who voluntarily consent to participate in the survey.

Exclusion criteria

Exclusion Criteria:

  • Participants under the age of 18 and non-English speaking participants.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1,434 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Frequency (percentage) of participants with aging-related skin concerns

    to determine the frequency of participants who indicate having aging-related skin concerns

    Time frame: 2 months

  2. Frequency (percentage) of participants with social and work life impact of age-related skin changes

    To determine the frequency of participants who indicate age-related skin changes impact their social and work life

    Time frame: 2 months

  3. Measure (count) the type of treatments participants are currently seeking for aging skin concerns

    To summarize the number of participants who would prioritize certain treatments for aging skin concerns

    Time frame: 2 months

Secondary outcomes

  1. Summarize (mean/standard deviations) demographic information

    Demographic information, including age, gender, race/ethnicity, geographic location, marital status and yearly household income will be summarize with means and standard deviations.

    Time frame: 2 months

07

Study locations

1 site
  • Northwestern University Fienberg School of Medicine Department of Dermatology
    Chicago, Illinois 60611, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04999748
Lead sponsor
Northwestern University
Responsible party
Roopal Kundu (Principal Investigator, Northwestern University) — Principal investigator
First posted
Aug 11, 2021
Start date
Jul 5, 2021
Primary completion
Aug 31, 2021
Completion
May 30, 2023
Last update
Nov 14, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion